LAM RESEARCH CORPORATION Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net
LAM RESEARCH CORPORATION (LRCX) reported Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net of $1.00 million for the 3-month period ending 2017-12-24, per its 10-Q filed 2019-01-30.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet · last filed 2019-01-30
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-12-24 was $1.00M, a 50.00% increase year-over-year.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-09-24 was $2.21M, a 257.37% increase year-over-year.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-06-25 was $2.61M, a 655.49% increase year-over-year.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for the quarter ending 2017-03-26 was $2.05M, a 550.16% increase year-over-year.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2017 was $5.95M, a 597.19% increase from fiscal 2016.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2016 was $853.00K.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2015 was -$87.00K, a 143.07% decline from fiscal 2014.
- LAM RESEARCH CORPORATION derivative instruments, gain (loss) recognized in income, ineffective portion and amount excluded from effectiveness testing, net for fiscal 2014 was $202.00K.
| Period end | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 3 month as first filed | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 6 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 9 month as first filed | Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net 12 month |
|---|---|---|---|---|---|---|
| 2017-12-24 | $1.00M 10-Q · filed 2019-01-30 | $3.21M 10-Q · filed 2019-01-30 | $5.82M derived: sum of 3 quarters · filed 2019-01-30 | $7.87M derived: sum of 4 quarters · filed 2019-01-30 | ||
| 2017-09-24 | $2.21M 10-Q · filed 2018-10-23 | $4.82M derived: sum of 2 quarters · filed 2018-10-23 | $6.87M derived: sum of 3 quarters · filed 2018-10-23 | $7.54M derived: sum of 4 quarters · filed 2018-10-23 | ||
| 2017-06-25 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-14 | $4.66M derived: sum of 2 quarters · filed 2018-08-14 | $5.33M derived: sum of 3 quarters · filed 2018-08-14 | $5.95M 10-K · filed 2018-08-14 | ||
| 2017-03-26 | $2.05M 10-Q · filed 2018-04-24 | $2.72M derived: sum of 2 quarters · filed 2018-04-24 | $3.33M 10-Q · filed 2018-04-24 | $3.68M derived: sum of 4 quarters · filed 2018-04-24 | ||
| 2016-12-25 | $668.00K 10-Q · filed 2018-01-30 | $1.28M 10-Q · filed 2018-01-30 | $1.63M derived: sum of 3 quarters · filed 2018-01-30 | $1.95M derived: sum of 4 quarters · filed 2018-01-30 | ||
| 2016-09-25 | $617.00K 10-Q · filed 2017-10-23 | $963.00K derived: sum of 2 quarters · filed 2017-10-23 | $1.28M derived: sum of 3 quarters · filed 2017-10-23 | $1.47M derived: sum of 4 quarters · filed 2017-10-23 | ||
| 2016-06-26 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-15 | $661.00K derived: sum of 2 quarters · filed 2017-08-15 | $850.00K derived: sum of 3 quarters · filed 2017-08-15 | $853.00K 10-K · filed 2017-08-15 | ||
| 2016-03-27 | $315.00K 10-Q · filed 2017-04-24 | $504.00K derived: sum of 2 quarters · filed 2017-04-24 | $507.00K 10-Q · filed 2017-04-24 | $535.00K derived: sum of 4 quarters · filed 2017-04-24 | ||
| 2015-12-27 | $189.00K 10-Q · filed 2017-01-30 | $192.00K 10-Q · filed 2017-01-30 | $220.00K derived: sum of 3 quarters · filed 2017-01-30 | $17.00K derived: sum of 4 quarters · filed 2017-01-30 | ||
| 2015-09-27 | $3.00K 10-Q · filed 2016-10-25 | $31.00K derived: sum of 2 quarters · filed 2016-10-25 | -$172.00K derived: sum of 3 quarters · filed 2016-10-25 | -$119.00K derived: sum of 4 quarters · filed 2016-10-25 | ||
| 2015-06-28 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-17 | -$175.00K derived: sum of 2 quarters · filed 2016-08-17 | -$122.00K derived: sum of 3 quarters · filed 2016-08-17 | -$87.00K 10-K · filed 2016-08-17 | ||
| 2015-03-29 | -$203.00K 10-Q · filed 2016-04-25 | $259.00K 10-Q · filed 2015-04-30 | -$150.00K derived: sum of 2 quarters · filed 2016-04-25 | -$115.00K 10-Q · filed 2016-04-25 | $347.00K 10-Q · filed 2015-04-30 | -$50.00K derived: sum of 4 quarters · filed 2016-04-25 |
| 2014-12-28 | $53.00K 10-Q · filed 2016-02-03 | $88.00K 10-Q · filed 2016-02-03 | $153.00K derived: sum of 3 quarters · filed 2016-02-03 | $192.00K derived: sum of 4 quarters · filed 2016-02-03 | ||
| 2014-09-28 | $35.00K 10-Q · filed 2015-11-03 | $100.00K derived: sum of 2 quarters · filed 2015-11-03 | $139.00K derived: sum of 3 quarters · filed 2015-11-03 | $191.00K derived: sum of 4 quarters · filed 2015-11-03 | ||
| 2014-06-29 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-13 | $104.00K derived: sum of 2 quarters · filed 2015-08-13 | $156.00K derived: sum of 3 quarters · filed 2015-08-13 | $202.00K 10-K · filed 2015-08-13 | ||
| 2014-03-30 | $39.00K 10-Q · filed 2014-05-08 | $91.00K derived: sum of 2 quarters · filed 2015-04-30 | $137.00K 10-Q · filed 2015-04-30 | $146.00K derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2013-12-29 | $52.00K 10-Q · filed 2015-02-03 | $98.00K 10-Q · filed 2015-02-03 | $107.00K derived: sum of 3 quarters · filed 2015-02-03 | $121.00K derived: sum of 4 quarters · filed 2015-02-03 | ||
| 2013-09-29 | $46.00K 10-Q · filed 2014-11-03 | $55.00K derived: sum of 2 quarters · filed 2014-11-03 | $69.00K derived: sum of 3 quarters · filed 2014-11-03 | |||
| 2013-06-30 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-26 | $23.00K derived: sum of 2 quarters · filed 2014-08-26 | -$33.00K 10-K · filed 2014-08-26 | |||
| 2013-03-31 | $14.00K 10-Q · filed 2014-05-08 | -$42.00K 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AXCELIS TECHNOLOGIES INC (ACLS) | United States | $3.583B | 63.11 |
| VEECO INSTRUMENTS INC (VECO) | United States | $2.777B | 199.41 |
| Azenta, Inc. (AZTA) | United States | $1.499B | -9.09 |
| ACM Research, Inc. (ACMR) | United States | $1.080B | 5.99 |
| Velo3D, Inc. (VELO) | United States | $0.354B | -10.81 |
| Energy Recovery, Inc. (ERII) | United States | $0.349B | 30.09 |
| AMTECH SYSTEMS INC (ASYS) | United States | $0.269B | 100.98 |
| SONO TEK CORP (SOTK) | United States | $0.075B | 37.58 |
| TRIO-TECH INTERNATIONAL (TRT) | United States | $0.075B | 587.94 |
| CVD EQUIPMENT CORP (CVV) | United States | $0.031B | 5.16 |